Don’t miss outtag icon
Get early access to Digital 100 2026, Similarweb’s official ranking of the fastest-growing brandsPre-register now!banner icon
NewBridge Pharmaceuticals FZ-LLC

十一月 2025

  • Home
  • NewBridge Pharmaceuticals FZ-LLC

十一月 2025的NewBridge Pharmaceutical...市场份额分析

成立年份2008
员工51 - 200
年营收$15M - $25M
nbpharma.com
NewBridge Pharmaceuticals FZ-LLC
NewBridge Pharmaceuticals FZ-LLC(包含公司地区分支机构)
  • nbpharma.com
    nbpharma.com
查看更多网站流量和参与度信息

NewBridge Pharmaceuticals FZ-LLC收入截至 十一月 2025为 15M - 25M

NewBridge Pharmaceuticals FZ-LLC主要域名产生的收入

3 年中NewBridge Pharmaceuticals FZ-LLC主要域名的收入

NewBridge Pharmaceuticals FZ-LLC主要域名的收入


NewBridge Pharmaceuticals FZ-LLC热门域名的总访问量

了解NewBridge Pharmaceuticals FZ-LLC市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细

NewBridge Pharmaceuticals FZ-LLC热门域名的平均访问时长

分析NewBridge Pharmaceuticals FZ-LLC参与度指标。

过去 3 个月的平均访问时长

子公司明细

NewBridge Pharmaceuticals FZ-LLC热门域名的平均页面浏览量

了解NewBridge Pharmaceuticals FZ-LLC如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细

想要获取更深入的流量洞见?

过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。



NewBridge Pharmaceuticals FZ-LLC 采用的主要技术

这些是排名前 NewBridge Pharmaceuticals FZ-LLC 的顶级域名所使用的网站技术(按行业分列)

小部件 (6)

转化和分析 (2)

Google Analytics

Google Analytics

移动设备 (2)

Meta Viewport

Meta Viewport

付费广告 (1)

DoubleClick

DoubleClick

更多技术

6

查看全部

准备好发现优质潜在客户了吗?

借助 Similarweb 销售情报解决方案,确定任意网站使用了哪些技术来设计完美的销售宣传,并缩短销售周期。


NewBridge Pharmaceuticals FZ-LLC 的新闻与信号

借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。

新闻BioCryst Pharmaceuticals, Inc. partnered with NewBridge Pharmaceuticals on Sep 1st '21.To support commercialization efforts in the UAE, BioCryst has entered into a supply and distribution agreement with NewBridge Pharmaceuticals, which also covers the Gulf Cooperation Council and Iraq.
新闻Pharming Group partners with NewBridge Pharmaceuticals.Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces it has entered into an exclusive licence agreement with NewBridge Pharmaceuticals ("NewBridge") for the distribution of RUCONEST® (conestat alfa) in the Middle East and North Africa ("MENA").
新闻NewBridge Pharmaceuticals received financing of $240M in financing on Dec 6th '17.The Massachusetts Development Finance Agency intends to come to market next week with a roughly $240 million financing for the NewBridge on the Charles project.

查看 NewBridge Pharmaceuticals FZ-LLC 的所有信号

让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。